Ezetimib-Mepha 10 mg, Tabletten - 100 Swissmedic Key 66070003 Registration Holder Mepha Pharma AG Name Ezetimib-Mepha 10 mg, Tabletten Date of registration 15.03.2017 Introduction of Sequence 15.03.2017 ATC-Classification Ezetimibe (C10AX09) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) 07.12. Show package size 100 Index Therapeuticus (Swissmedic) 07.12. Description Swissmedic categorie. B SL Eintrag No Indication Information for professionals IP Consumer information CI Deductible k.A. Feedback FB GTIN 7680660700033 Medication Code Synthetika Pharmacode Disponibility
Composition ezetimibum 10 mg, lactosum monohydricum 63 mg, carmellosum natricum conexum, hypromellosum, natrii laurilsulfas, crospovidonum, cellulosum microcristallinum, magnesii stearas, pro compresso corresp. natrium max. 1.32 mg. Packungsbestandteile Galenic Form Tablets Active Agent Dose Ezetimib 10 mg
BAG: Active Agent Dose Ezetimib 10 mg
Inactive agents Dose Carmellosum Natricum Conexum Cellulosum Microcristallinum Crospovidonum Hypromellosum Lactose Monohydrate 63 mg Magnesii Stearas Natrii Laurilsulfas Pro Compresso
Source Data was imported : 19.11.2025
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
